Intermediate and high-risk non-muscle-invasive bladder cancer: an overview of epidemiology, burden, and unmet needs
K Grabe-Heyne, C Henne, P Mariappan… - Frontiers in …, 2023 - frontiersin.org
Bladder cancer ranks among the most common cancers globally. At diagnosis, 75% of
patients have non-muscle-invasive bladder cancer (NMIBC). Patients with low-risk NMIBC …
patients have non-muscle-invasive bladder cancer (NMIBC). Patients with low-risk NMIBC …
The Utility of Intraluminal Therapies in Upper Tract Urothelial Carcinoma: A Narrative Review
J Tyrrell, W Chui, J Kealey, S Sengupta - Cancers, 2024 - mdpi.com
Simple Summary Tumours of the lining of the kidney and its drainage tube (the ureter) can
be treated by surgery carried out through fine telescopes. There is an increased risk of …
be treated by surgery carried out through fine telescopes. There is an increased risk of …
The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis
S Moretto, A Piccolini, A Gallioli, R Contieri… - … Oncology: Seminars and …, 2024 - Elsevier
Introduction Intravesical recurrence of upper tract urothelial carcinoma after radical
nephroureterectomy occurs in 22% to 47%. Intravesical chemotherapy is still underused due …
nephroureterectomy occurs in 22% to 47%. Intravesical chemotherapy is still underused due …